annual cash & cash equivalents:
$412.67M+$226.43M(+121.58%)Summary
- As of today (August 31, 2025), SMMT annual cash & cash equivalents is $412.67 million, with the most recent change of +$226.43 million (+121.58%) on December 31, 2024.
- During the last 3 years, SMMT annual cash & cash equivalents has risen by +$340.88 million (+474.83%).
- SMMT annual cash & cash equivalents is now -36.38% below its all-time high of $648.61 million, reached on December 31, 2022.
Performance
SMMT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$298.19M-$63.44M(-17.54%)Summary
- As of today (August 31, 2025), SMMT quarterly cash & cash equivalents is $298.19 million, with the most recent change of -$63.44 million (-17.54%) on June 30, 2025.
- Over the past year, SMMT quarterly cash & cash equivalents has dropped by -$27.60 million (-8.47%).
- SMMT quarterly cash & cash equivalents is now -54.03% below its all-time high of $648.61 million, reached on December 31, 2022.
Performance
SMMT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SMMT Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +121.6% | -8.5% |
3 y3 years | +474.8% | +420.1% |
5 y5 years | +543.4% | - |
SMMT Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -36.4% | +474.8% | -54.0% | +420.1% |
5 y | 5-year | -36.4% | +543.4% | -54.0% | +1301.9% |
alltime | all time | -36.4% | >+9999.0% | -54.0% | >+9999.0% |
SMMT Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $298.19M(-17.5%) |
Mar 2025 | - | $361.63M(-12.4%) |
Dec 2024 | $412.67M(+121.6%) | $412.67M(-15.3%) |
Sep 2024 | - | $487.22M(+49.6%) |
Jun 2024 | - | $325.79M(+107.5%) |
Mar 2024 | - | $157.00M(-15.7%) |
Dec 2023 | $186.24M(-71.3%) | $186.24M(-6.4%) |
Sep 2023 | - | $198.94M(-7.5%) |
Jun 2023 | - | $215.01M(-11.1%) |
Mar 2023 | - | $241.93M(-62.7%) |
Dec 2022 | $648.61M(+803.5%) | $648.61M(+431.8%) |
Sep 2022 | - | $121.97M(+112.7%) |
Jun 2022 | - | $57.34M(-26.0%) |
Mar 2022 | - | $77.45M(+7.9%) |
Dec 2021 | $71.79M(+8.1%) | $71.79M(-10.5%) |
Sep 2021 | - | $80.25M(-22.4%) |
Jun 2021 | - | $103.39M(+1.2%) |
Mar 2021 | - | $102.19M(+53.9%) |
Dec 2020 | $66.42M(+3.5%) | - |
Dec 2020 | - | $66.42M(+212.3%) |
Sep 2020 | - | $21.27M(-61.4%) |
Mar 2020 | - | $55.05M(+55.8%) |
Dec 2019 | $64.14M(+124.4%) | - |
Jan 2019 | - | $35.33M(+112.0%) |
Oct 2018 | - | $16.67M(-25.8%) |
Jul 2018 | - | $22.47M(-39.3%) |
Apr 2018 | - | $36.99M(+29.4%) |
Jan 2018 | $28.59M(-19.0%) | - |
Jan 2018 | - | $28.59M(-32.3%) |
Oct 2017 | - | $42.24M(+13.3%) |
Jul 2017 | - | $37.30M(+48.9%) |
Apr 2017 | - | $25.05M(-29.0%) |
Jan 2017 | $35.30M(+52.7%) | - |
Jan 2017 | - | $35.30M(-16.5%) |
Oct 2016 | - | $42.28M(+355.2%) |
Jul 2016 | - | $9.29M(-36.5%) |
Apr 2016 | - | $14.63M(-36.7%) |
Jan 2016 | $23.13M | - |
Date | Annual | Quarterly |
---|---|---|
Jan 2016 | - | $23.13M(-32.5%) |
Oct 2015 | - | $34.27M(-16.9%) |
Jul 2015 | - | $41.25M(-8.7%) |
Apr 2015 | - | $45.20M(+167.2%) |
Jan 2015 | $16.92M(+407.1%) | - |
Jan 2015 | - | $16.92M(-29.5%) |
Oct 2014 | - | $24.01M(-18.6%) |
Jul 2014 | - | $29.49M(+780.7%) |
Jan 2014 | $3.34M(-37.7%) | - |
Jan 2014 | - | $3.35M(-63.4%) |
Jul 2013 | - | $9.15M(+71.4%) |
Jan 2013 | $5.36M(+63.5%) | - |
Jan 2013 | - | $5.34M(-28.5%) |
Jul 2012 | - | $7.47M(+129.1%) |
Jan 2012 | $3.28M(-37.1%) | - |
Jan 2012 | - | $3.26M(-46.1%) |
Jul 2011 | - | $6.04M(+17.5%) |
Jan 2011 | $5.21M(-46.6%) | - |
Jan 2011 | - | $5.14M(-27.9%) |
Jul 2010 | - | $7.13M(-26.6%) |
Jan 2010 | $9.75M(+148.8%) | - |
Jan 2010 | - | $9.72M(+575.5%) |
Jul 2009 | - | $1.44M(-63.3%) |
Jan 2009 | $3.92M(-80.5%) | - |
Jan 2009 | - | $3.92M(-75.3%) |
Jul 2008 | - | $15.86M(-21.0%) |
Jan 2008 | $20.05M(-44.0%) | - |
Jan 2008 | - | $20.06M(-30.6%) |
Jul 2007 | - | $28.91M(-19.4%) |
Jan 2007 | $35.80M(+59.4%) | - |
Jan 2007 | - | $35.87M(-5.0%) |
Jul 2006 | - | $37.77M(+1934.2%) |
Jan 2006 | $22.45M(-15.9%) | - |
Jan 2006 | - | $1.86M(-91.8%) |
Jul 2005 | - | $22.67M(-15.0%) |
Jan 2005 | $26.71M(>+9900.0%) | - |
Jan 2005 | - | $26.66M(>+9900.0%) |
Jul 2004 | - | $176.70K |
Jan 2004 | $144.90K | - |
FAQ
- What is Summit Therapeutics Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual cash & cash equivalents year-on-year change?
- What is Summit Therapeutics Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
What is Summit Therapeutics Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SMMT is $412.67M
What is the all time high annual cash & cash equivalents for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual cash & cash equivalents is $648.61M
What is Summit Therapeutics Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SMMT annual cash & cash equivalents has changed by +$226.43M (+121.58%)
What is Summit Therapeutics Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SMMT is $298.19M
What is the all time high quarterly cash & cash equivalents for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly cash & cash equivalents is $648.61M
What is Summit Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SMMT quarterly cash & cash equivalents has changed by -$27.60M (-8.47%)